Skip to main content

Table 4 TT, FT, and SHBG change from baseline after 3, 6, and 12 months of TRT, by baseline testosterone level quartiles

From: Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

 

Quartile 1

(<206 ng/dL)

[<7.1 nmol/L]

Quartile 2

(206-256 ng/dL)

[7.1-8.9 nmol/L]

Quartile 3

(257-330 ng/dL)

[8.9-11.5 nmol/L]

Quartile 4

(≥331 ng/dL)

[≥11.5 nmol/L]

p-Value, Differences Among Quartiles

 

Mean Value, Mean Change from Baseline

(p-Value for Change from Baseline)

Mean Value

Mean Change From Baseline

TT, ng/dL [nmol/L]

      

   3 Months

465 [16.1], +307

(<0.0001)

466 [16.2], +234

(<0.0001)

543 [18.8], +248

(0.0002)

520 [18.0], +59

(0.3)

0.7

0.02

   6 Months

405 [14.1], +244

(<0.0001)

379 [13.2], +148

(0.0007)

425 [14.7], +135

(0.01)

535 [18.6], -3.7

(0.9)

0.09

0.002

   12 Months

519 [18.0], +359

(<0.0001)

456 [15.8], +225

(<0.0001)

496 [17.2], +206

(0.0003)

520 [18.0], +3.6

(0.9)

0.7

<0.0001

FT, pg/mL [pmol/L]

      

   3 Months

74 [256.8], +32

(0.1)

93 [322.7], +19

(0.5)

121 [419.9], +80

(0.0002)

80 [277.6], +17

(0.03)

0.3

0.1

   6 Months

84 [291.5], +57

(0.0007)

71 [246.4], +3.8

(0.8)

82 [284.5], +45

(0.02)

69 [239.4], +6.3

(0.7)

0.8

0.06

   12 Months

87 [301.9], +59

(0.0008)

67 [232.5], +9.0

(0.7)

56 [194.3], +18

(0.3)

70 [242.9], +6.9

(0.7)

0.5

0.1

SHBG, nmol/L

      

   3 Months

27.9, +2.83

(0.7)

24.1, +0.1

(1.0)

32.1, +1.52

(0.7)

37.2, -1.66

(0.7)

0.2

0.9

   6 Months

25.6, -1.00

(0.9)

25.7, +3.30

(0.6)

26.5, -3.84

(0.4)

38.9, -1.49

(0.7)

0.06

0.8

   12 Months

19.4, -6.50

(0.4)

20.7, -1.45

(0.8)

25.2, -6.72

(0.1)

45.8, +5.75

(0.3)

0.002

0.3

  1. Abbreviations: FT = free testosterone; SHBG = sex hormone-binding globulin; TT = total testosterone.